Oculis
The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. Furthermore, the technique has been demonstrated to allow diseases at the anterior part of the eye to be treated with a reduced number of topical applications compared to conventional eye-drops.
Tech Stack (22 technologies)
Frequently Asked Questions
What technologies does Oculis use?+
Oculis uses 22 technologies including Cookiebot, Google Analytics, Google Tag Manager.
What industry is Oculis in?+
Oculis operates in the Biotechnology industry.
Where is Oculis based?+
Oculis is headquartered in Switzerland.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026